Clinical Trials Browser

Completed × Prostatic Neoplasms × Biopsy × Clear all

NCT05730712 2026-02-06

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT02769962 2025-07-28

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Phase 1/2 Completed

45 enrolled 30 charts

GenitourinaryThoracic

Carcinoma, Transitional Cell, Lung Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT05655715 2024-10-16

CheckPRO

Phase 2 Completed

Neoplasms, Prostatic Neoplasms

NCT02933255 2024-05-31

PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer

Phase 1/2 Completed

24 enrolled 20 charts

Prostatic Neoplasms

NCT02555189 2024-05-13

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Phase 1/2 Completed

Prostatic Neoplasms

NCT03225222 2023-09-07

MR-PROPER

Prostatic Neoplasms

NCT05069584 2023-05-23

PERFECT

Phase NA Completed

Prostatic Neoplasms

NCT04247217 2022-05-26

PRIMUS

Prostatic Neoplasms

NCT02229565 2020-11-13

GENCADE

Prostatic Neoplasms

NCT00082147 2018-06-13

Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer

Phase NA Completed

Prostatic Neoplasms

NCT00898326 2017-06-02

SHIP36B

Prostatic Neoplasms

NCT00373035 2017-01-19

Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy

Prostatic Neoplasms

NCT00459407 2014-10-08

Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate

Phase 1 Completed

Prostatic Neoplasms

NCT00416390 2013-09-20

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

Phase NA Completed

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms

NCT00561314 2013-08-26

High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer

Phase 2 Completed

GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

NCT00562380 2013-07-18

AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

Phase 1 Completed

DermatologicGenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Prostatic Neoplasms, Sarcoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Neuroectodermal Tumors, Primitive, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Desmoplastic Small Round Cell Tumor